Drug Type Biosimilar, Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D02598 | Infliximab biosimilar(Ospedale San Raffaele SRL) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Takayasu Arteritis | Phase 1 | - | - |
Not Applicable | 109 | (Ulcerative Colitis) | ccqbtajlwp(qwpbzuhmoq) = zgtsxempuo rvmcletazs (cdybsrzuzc ) | Positive | 05 Oct 2025 | ||
(Crohn's Disease) | ccqbtajlwp(qwpbzuhmoq) = sacsogbsip rvmcletazs (cdybsrzuzc ) |






